108 related articles for article (PubMed ID: 28986802)
1. Re-expressing Epigenetically Silenced Genes by Inducing DNA Demethylation Through Targeting of Ten-Eleven Translocation 2 to Any Given Genomic Locus.
Rendón JC; Cano-Rodríguez D; Rots MG
Methods Mol Biol; 2017; 1654():321-335. PubMed ID: 28986802
[TBL] [Abstract][Full Text] [Related]
2. Induced DNA demethylation by targeting Ten-Eleven Translocation 2 to the human ICAM-1 promoter.
Chen H; Kazemier HG; de Groote ML; Ruiters MH; Xu GL; Rots MG
Nucleic Acids Res; 2014 Feb; 42(3):1563-74. PubMed ID: 24194590
[TBL] [Abstract][Full Text] [Related]
3. Remodeling epigenetic modifications at tumor suppressor gene promoters with bovine oocyte extract.
Wang Z; Yue Y; Han P; Sa R; Ren X; Wang J; Bai H; Yu H
Cytotherapy; 2013 Sep; 15(9):1164-73. PubMed ID: 23800731
[TBL] [Abstract][Full Text] [Related]
4. Re-expression of Selected Epigenetically Silenced Candidate Tumor Suppressor Genes in Cervical Cancer by TET2-directed Demethylation.
Huisman C; van der Wijst MG; Schokker M; Blancafort P; Terpstra MM; Kok K; van der Zee AG; Schuuring E; Wisman GB; Rots MG
Mol Ther; 2016 Mar; 24(3):536-47. PubMed ID: 26686387
[TBL] [Abstract][Full Text] [Related]
5. Prolonged re-expression of the hypermethylated gene EPB41L3 using artificial transcription factors and epigenetic drugs.
Huisman C; van der Wijst MG; Falahi F; Overkamp J; Karsten G; Terpstra MM; Kok K; van der Zee AG; Schuuring E; Wisman GB; Rots MG
Epigenetics; 2015; 10(5):384-96. PubMed ID: 25830725
[TBL] [Abstract][Full Text] [Related]
6. Rewriting DNA Methylation Signatures at Will: The Curable Genome Within Reach?
Stolzenburg S; Goubert D; Rots MG
Adv Exp Med Biol; 2016; 945():475-490. PubMed ID: 27826848
[TBL] [Abstract][Full Text] [Related]
7. TLR2-ICAM1-Gadd45α axis mediates the epigenetic effect of selenium on DNA methylation and gene expression in Keshan disease.
Yang G; Zhu Y; Dong X; Duan Z; Niu X; Wei J
Biol Trace Elem Res; 2014 Jun; 159(1-3):69-80. PubMed ID: 24811888
[TBL] [Abstract][Full Text] [Related]
8. SOX30, a novel epigenetic silenced tumor suppressor, promotes tumor cell apoptosis by transcriptional activating p53 in lung cancer.
Han F; Liu W; Jiang X; Shi X; Yin L; Ao L; Cui Z; Li Y; Huang C; Cao J; Liu J
Oncogene; 2015 Aug; 34(33):4391-402. PubMed ID: 25435374
[TBL] [Abstract][Full Text] [Related]
9. Reversible epigenetic fingerprint-mediated glutathione-S-transferase P1 gene silencing in human leukemia cell lines.
Karius T; Schnekenburger M; Ghelfi J; Walter J; Dicato M; Diederich M
Biochem Pharmacol; 2011 Jun; 81(11):1329-42. PubMed ID: 21453686
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic silencing of LPP/miR-28 in multiple myeloma.
Li Z; Wong KY; Chan GC; Chim CS
J Clin Pathol; 2018 Mar; 71(3):253-258. PubMed ID: 28775176
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells.
Zhang C; Li H; Zhou G; Zhang Q; Zhang T; Li J; Zhang J; Hou J; Liew CT; Yin D
J Pathol; 2007 Jun; 212(2):134-42. PubMed ID: 17471463
[TBL] [Abstract][Full Text] [Related]
12. A Genome-Wide Methylation Approach Identifies a New Hypermethylated Gene Panel in Ulcerative Colitis.
Kang K; Bae JH; Han K; Kim ES; Kim TO; Yi JM
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27517910
[TBL] [Abstract][Full Text] [Related]
13. Targeted DNA demethylation of the
Gallego-Bartolomé J; Gardiner J; Liu W; Papikian A; Ghoshal B; Kuo HY; Zhao JM; Segal DJ; Jacobsen SE
Proc Natl Acad Sci U S A; 2018 Feb; 115(9):E2125-E2134. PubMed ID: 29444862
[TBL] [Abstract][Full Text] [Related]
14. Global alterations of DNA methylation in cholangiocarcinoma target the Wnt signaling pathway.
Goeppert B; Konermann C; Schmidt CR; Bogatyrova O; Geiselhart L; Ernst C; Gu L; Becker N; Zucknick M; Mehrabi A; Hafezi M; Klauschen F; Stenzinger A; Warth A; Breuhahn K; Renner M; Weichert W; Schirmacher P; Plass C; Weichenhan D
Hepatology; 2014 Feb; 59(2):544-54. PubMed ID: 24002901
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic silencing of endothelin-3 in colorectal cancer.
Olender J; Nowakowska-Zajdel E; Kruszniewska-Rajs C; Orchel J; Mazurek U; Wierzgoń A; Kokot T; Muc-Wierzgoń M
Int J Immunopathol Pharmacol; 2016 Jun; 29(2):333-40. PubMed ID: 26684626
[TBL] [Abstract][Full Text] [Related]
16. The dual specificity phosphatase 2 gene is hypermethylated in human cancer and regulated by epigenetic mechanisms.
Haag T; Richter AM; Schneider MB; Jiménez AP; Dammann RH
BMC Cancer; 2016 Feb; 16():49. PubMed ID: 26833217
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic regulation of tumor endothelial cell anergy: silencing of intercellular adhesion molecule-1 by histone modifications.
Hellebrekers DM; Castermans K; Viré E; Dings RP; Hoebers NT; Mayo KH; Oude Egbrink MG; Molema G; Fuks F; van Engeland M; Griffioen AW
Cancer Res; 2006 Nov; 66(22):10770-7. PubMed ID: 17108113
[TBL] [Abstract][Full Text] [Related]
18. Genetic unmasking of epigenetically silenced tumor suppressor genes in colon cancer cells deficient in DNA methyltransferases.
Paz MF; Wei S; Cigudosa JC; Rodriguez-Perales S; Peinado MA; Huang TH; Esteller M
Hum Mol Genet; 2003 Sep; 12(17):2209-19. PubMed ID: 12915469
[TBL] [Abstract][Full Text] [Related]
19. Towards sustained silencing of HER2/neu in cancer by epigenetic editing.
Falahi F; Huisman C; Kazemier HG; van der Vlies P; Kok K; Hospers GA; Rots MG
Mol Cancer Res; 2013 Sep; 11(9):1029-39. PubMed ID: 23814024
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic silencing of the interferon regulatory factor ICSBP/IRF8 in human multiple myeloma.
Tshuikina M; Jernberg-Wiklund H; Nilsson K; Oberg F
Exp Hematol; 2008 Dec; 36(12):1673-1681. PubMed ID: 18922617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
